Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML

Allogeneic hematopoietic stem cell transplantation (alloHCT) represents the only potentially curative treatment in high-risk AML patients, but up to 40% of patients suffer from relapse after alloHCT. Treatment of overt relapse poses a major therapeutic challenge and long-term disease control is achi...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgi, Julia-Annabell, Stasik, Sebastian, Bornhäuser, Martin, Platzbecker, Uwe, Thiede, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892234/
https://www.ncbi.nlm.nih.gov/pubmed/35252010
http://dx.doi.org/10.3389/fonc.2022.841608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892234/
https://www.ncbi.nlm.nih.gov/pubmed/35252010
http://dx.doi.org/10.3389/fonc.2022.841608

Ejemplares similares